Single circulating tumor cell sequencing as an advanced tool in cancer management

Expert Review of Molecular Diagnostics

Volumn 16, Issue 1, 2016, Pages 51-63

  Salvianti, Francesca ^a   Pazzagli, Mario ^a   Pinzani, Pamela ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

CTC enrichment; liquid biopsy; next generation sequencing; single cell; whole genome amplification

Indexed keywords

EPITHELIAL CELL ADHESION MOLECULE;

BLOOD SAMPLING; CANCER CELL; CANCER PATIENT; CANCER THERAPY; CIRCULATING TUMOR CELL; DENSITY GRADIENT CENTRIFUGATION; DNA DETERMINATION; EPITHELIAL MESENCHYMAL TRANSITION; FLUORESCENCE ACTIVATED CELL SORTING; GENE AMPLIFICATION; HUMAN; IMMUNOMAGNETIC SEPARATION; METASTASIS POTENTIAL; NEXT GENERATION SEQUENCING; POINT MUTATION; PROTEIN EXPRESSION; REVIEW; SINGLE CELL ANALYSIS; BIOPSY; BLOOD; DNA SEQUENCE; GENETICS; METABOLISM; METASTASIS; MUTATION; NEOPLASM; PATHOLOGY; TUMOR EMBOLISM;

BIOPSY; HUMANS; MUTATION; NEOPLASM METASTASIS; NEOPLASMS; NEOPLASTIC CELLS, CIRCULATING; SEQUENCE ANALYSIS, DNA; SINGLE-CELL ANALYSIS;

EID: 84955185255     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.2016.1116942     Document Type: Review

References (61)

1. Ashworth TR. A case of cancer in which cells similar to those in the tumors were seen in the blood after death. Aus Med J. 1869;14:146-147.
2. Shlush LI, Hershkovitz D. Clonal evolution models of tumor heterogeneity. Am Soc Clin Oncol Educ Book. 2015;35: e662-5.
3. De Bruin EC, McGranahan N, Mitter R, et al. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science. 2014;346 (6206):251-256.
4. Merlo LM, Shah NA, Li X, et al. A comprehensive survey of clonal diversity measures in Barrett's esophagus as biomarkers of progression to esophageal adenocarcinoma. Cancer Prev Res (Phila). 2010;3 (11):1388-1397.
5. Yoon HH, Shi Q, Sukov WR, et al. Adverse prognostic impact of intratumor heterogeneous HER2 gene amplification in patients with esophageal adenocarcinoma. J Clin Oncol. 2012;30 (32):3932-3938.
6. Seol H, Lee HJ, Choi Y, et al. Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance. Mod Pathol. 2012;25 (7):938-948.
7. Mroz EA, Tward AD, Pickering CR, et al. High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma. Cancer. 2013;119 (16):3034-3042.
8. Tannock IF. Biology and tumor growth. Hosp Pract (Off Ed). 1983;18 (4):81-93.
9. Hüsemann Y, Geigl JB, Schubert F, et al. Systemic spread is an early step in breast cancer. Cancer Cell. 2008;13 (1):58-68.
10. Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science. 2011;331 (6024):1559-1564.
11. Pienta KJ, McGregor N, Axelrod R, et al. Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments. Transl Oncol. 2008;1 (4):158-164.
12. McGovern M, Voutev R, Maciejowski J, et al. A "latent niche" mechanism for tumor initiation. Proc Natl Acad Sci USA. 2009;106 (28):11617-11622.
13. Cristofanilli M, Hayes DF, Budd GT, et al. Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol. 2005;23:1420-1430.
14. Cohen SJ, Punt CJ, Iannotti N, et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol. 2008;26:3213-3221.
15. de Bono JS, Scher HI, Montgomery RB, et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin. Cancer. Res. 2008;14:6302-6309.
16. Low WS, Wan Abas WA. Benchtop technologies for circulating tumor cells separation based on biophysical properties. Biomed Res Int. 2015;2015:239362.
17. Alix-Panabières C, Pantel K. Circulating tumor cells: liquid biopsy of cancer. Clin Chem. 2013;59 (1):110-118.
18. Navin N, Hicks J. Future medical applications of single-cell sequencing in cancer. Genome Med. 2011;3 (5):31.
19. Cann GM, Gulzar ZG, Cooper S, et al. mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer. PLoS One. 2012;7 (11): e49144.
20. Ramsköld D, Luo S, Wang YC, et al. Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells. Nat Biotechnol. 2012;30 (8):777-782.
21. Chen CL, Mahalingam D, Osmulski P, et al. Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer. Prostate. 2013;73 (8):813-826.
22. Powell AA, Talasaz AH, Zhang H, et al. Single cell profiling of circulating tumor cells: Transcriptional heterogeneity and diversity from breast cancer cell lines. PLoS One. 2012;7 (5):e33788.
23. Sandberg R. Entering the era of single-cell transcriptomics in biology and medicine. Nat Methods. 2014;11 (1):22-24.
24. Qin J, Alt JR, Hunsley BA, et al. Stabilization of circulating tumor cells in blood using a collection device with a preservative reagent. Cancer Cell Int. 2014;14 (1):23.
25. Fernando MR, Norton SE, Luna KK, et al. Stabilization of cell-free RNA in blood samples using a new collection device. Clin Biochem. 2012;45 (16-17):1497-1502.
26. Norton SE, Lechner JM, Williams T, et al. A stabilizing reagent prevents cellfree DNA contamination by cellular DNA in plasma during blood sample storage and shipping as determined by digital PCR. Clin Biochem. 2013;46 (15):1561-1565.
27. Polzer B, Medoro G, Pasch S, et al. Molecular profiling of single circulating tumor cells with diagnostic intention. EMBO Mol Med. 2014;6 (11):1371-1386.
28. Fernandez SV, Bingham C, Fittipaldi P, et al. TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients. Breast Cancer Res. 2014;16 (5):445.
29. Pestrin M, Salvianti F, Galardi F, et al. Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients. Mol Oncol. 2015;9 (4):749-757.
30. Heitzer E, Auer M, Gasch C, et al. Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing. Cancer Res. 2013;73 (10):2965-2975.
31. Gasch C, Bauernhofer T, Pichler M, et al. Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/ PIK3CA in circulating tumor cells of patients with colorectal cancer. Clin Chem. 2013;59 (1):252-260.
32. Ni X, Zhuo M, Su Z, et al. Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients. Proc Natl Acad Sci USA. 2013;110 (52):21083-21088.
33. Reátegui E, Aceto N, Lim EJ, et al. Tunable nanostructured coating for the capture and selective release of viable circulating tumor cells. Adv Mater. 2015;27 (9):1593-1599.
34. Sakaizawa K, Goto Y, Kiniwa Y, et al. Mutation analysis of BRAF and KIT in circulating melanoma cells at the single cell level. Br J Cancer. 2012;106 (5):939-946.
35. Dago AE, Stepansky A, Carlsson A, et al. Rapid phenotypic and genomic change in response to therapeutic pressure in prostate cancer inferred by high content analysis of single circulating tumor cells. PLoS One. 2014;9 (8):e101777.
36. Deng G, Krishnakumar S, Powell AA, et al. Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow. BMC Cancer. 2014;14:456.
37. Lohr JG, Adalsteinsson VA, Cibulskis K, et al. Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer. Nat Biotechnol. 2014;32 (5):479-484.
38. Fabbri F, Carloni S, Zoli W, et al. Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs. Cancer Lett. 2013;335 (1):225-231.
39. Zhao L, Lu YT, Li F, et al. High-purity prostate circulating tumor cell isolation by a polymer nanofiber-embedded microchip for whole exome sequencing. Adv Mater. 2013;25:2897-2902.
40. Alix-Panabières C, Schwarzenbach H, Pantel K. Circulating tumor cells and circulating tumor DNA. Annu Rev Med. 2012;63:199-215.
41. Joosse SA, Gorges TM, Pantel K. Biology, detection, and clinical implications of circulating tumor cells. EMBO Mol Med. 2014;7 (1):1-11.
42. Talasaz AH, Powell AA, Huber DE, et al. Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device. Proc Natl Acad Sci USA. 2009;106 (10):3970-3975.
43. Nagrath S, Sequist LV, Maheswaran S, et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature. 2007;450 (7173):1235-1239.
44. Saucedo-Zeni N, Mewes S, Niestroj R, et al. A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire. Int J Oncol. 2012;41 (4):1241-1250.
45. Vona G, Sabile A, Louha M, et al. Isolation by size of epithelial tumor cells: A new method for the immunomorphological and molecular characterization of circulatingtumor cells. Am J Pathol. 2000;156 (1):57-63.
46. Desitter I, Guerrouahen BS, Benali-Furet N, et al. A new device for rapid isolation by size and characterization of rare circulating tumor cells. Anticancer Res. 2011;31 (2):427-441.
47. Sollier E, Go DE, Che J, et al. Size-selective collection of circulating tumor cells using Vortex technology. Lab Chip. 2014;14 (1):63-77.
48. Hou HW, Warkiani ME, Khoo BL, et al. Isolation and retrieval of circulating tumor cells using centrifugal forces. Sci Rep. 2013;3:1259.
49. Tan SJ, Lakshmi RL, Chen P, et al. Versatile label free biochip for the detection of circulating tumor cells from peripheral blood in cancer patients. Biosens Bioelectron. 2010;26 (4):1701-1705.
50. Tan SJ, Yobas L, Lee GY, et al. Microdevice for the isolation and enumeration of cancer cells from blood. Biomed Microdevices. 2009;11 (4):883-892.
51. Sarioglu AF, Aceto N, Kojic N, et al. A microfluidic device for label-free, physical capture of circulating tumor cell clusters. Nat Methods. 2015;12 (7):685-691.
52. Aceto N, Bardia A, Miyamoto DT, et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014;158 (5):1110-1122.
53. Ozkumur E, Shah AM, Ciciliano JC, et al. Inertial focusing for tumor antigendependent and-independent sorting of rare circulating tumor cells. Sci Transl Med. 2013;5 (179):179ra47.
54. Shapiro E, Biezuner T, Linnarsson S. Single-cell sequencing-based technologies will revolutionize whole-organism science. Nat Rev Genet. 2013;14 (9):618-630.
55. Navin NE. Cancer genomics: one cell at a time. Genome Biol. 2014;15 (8):452.
56. Fuchs AB, Romani A, Freida D, et al. Electronic sorting and recovery of single live cells from microlitre sized samples. Lab Chip. 2006;6 (1):121-126.
57. Peeters DJ, De Laere B, Van den Eynden GG, et al. Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting. Br J Cancer. 2013;108 (6):1358-1367.
58. Blainey PC. The future is now: single-cell genomics of bacteria and archaea. FEMS Microbiol Rev. 2013;37 (3):407-427.
59. Van Loo P, Voet T. Single cell analysis of cancer genomes. Curr Opin Genet Dev. 2014;24:82-91.
60. McInerney P, Adams P, Hadi MZ. Error rate comparison during polymerase chain reaction by DNA polymerase. Mol Biol Int. 2014;2014:287430.
61. Treff NR, Su J, Tao X, et al. Single-cell whole-genome amplification technique impacts the accuracy of SNP microarraybased genotyping and copy number analyses. Mol Hum Reprod. 2011;17 (6):335-343.